A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer
Clinical trial NCT05325229 · UNKNOWN
Trial details
- NCT number
- NCT05325229
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2024-12-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.